Clinical Performance of Investigational InRhythm PT/INR System in a Professional Use Setting

A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding/Pharmacodynamics in Healthy Participants

NCT02561923 ·Status: COMPLETED ·Phase: PHASE1

Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX

NCT04628871 ·Status: ACTIVE_NOT_RECRUITING

Clinical Trial on Treatment of Intraventricular Hemorrhage

NCT00650858 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.

NCT04060836 ·Status: UNKNOWN ·Phase: PHASE1

Platelet-Rich Plasma Intra-Articular Injection in Treating Hemophilic Arthropathy

NCT02601170 ·Status: COMPLETED ·Phase: NA

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy

NCT00708435 ·Status: COMPLETED ·Phase: PHASE3

ASC618 Gene Therapy in Hemophilia A Patients

NCT04676048 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A

NCT00621673 ·Status: TERMINATED ·Phase: PHASE4

Low-Cost Platelet-Rich Plasma for Hemarthropathy

NCT06543368 ·Status: COMPLETED ·Phase: NA

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

NCT01410227 ·Status: COMPLETED ·Phase: PHASE3

Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia

NCT01408732 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia

NCT01598168 ·Status: TERMINATED ·Phase: PHASE3

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

NCT00306670 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.

NCT02246868 ·Status: COMPLETED ·Phase: PHASE3

TFPI Levels in Haemophilia A and B Patients

NCT04570696 ·Status: UNKNOWN

Dose Response to Recombinant Factor VIIa When Administered for Bleed

NCT00104455 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia

NCT01439971 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A

NCT02888223 ·Status: UNKNOWN ·Phase: PHASE1

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors

NCT06569108 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders

NCT02324517 ·Status: UNKNOWN

Clinical and Health-related Outcome of rFVIIIFc Prophylaxis

NCT04583930 ·Status: UNKNOWN

Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

NCT01406639 ·Status: WITHDRAWN ·Phase: PHASE1

A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.

NCT02250560 ·Status: COMPLETED ·Phase: PHASE3

A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers

NCT00951873 ·Status: COMPLETED ·Phase: PHASE1